Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hodgkin Disease × prednylidene × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Subcutaneous panniculitis-like T-cell lymphoma 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Enteropathy-Associated T-Cell Lymphoma 1

Interventions

Cyclophosphamide 2 Brentuximab Vedotin 2 tislelizumab 1 sintilimab 1 prednylidene 1 Watchful Waiting 1 Vinblastine 1 Thiotepa 1 Radiotherapy 1 Prednisolone 1 Pentoxifylline 1 Filgrastim 1 Bendamustine Hydrochloride 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01088750 2023-12-13

EuroNetLP1

Martin-Luther-Universität Halle-Wittenberg

Phase 4 Completed

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡